Proteomic and metabolomic approaches elucidate the molecular mechanism of emodin against neuropathic pain through modulating the gamma‐aminobutyric acid (GABA)‐ergic pathway and PI3K/AKT/NF‐κB pathway
Authors:
- 1 February 2023
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 37 (5) , 1883-1899
Abstract
Neuropathic pain (NeP) is a major health concern. Due to the complex pathological mechanisms, management of NeP is challenging. Emodin, a natural anthraquinone derivative, exerts excellent analgesic effects. However, its mechanisms of action are still poorly understood. In this study, we investigated the mechanisms underlying pain‐relief effects of emodin in the cerebral cortex using proteomic and metabolomic approaches. After 15 days of emodin administration, the mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) values in the emodin groups were significantly higher than those in the chronic constriction injury (CCI) group (p < .05), suggesting emodin treatment could reverse CCI‐induced hyperalgesia. Emodin treatment evoked the expression alteration of 402 proteins (153 up‐regulated and 249 down‐regulated) in the CCI models, which were primarily involved in PI3K/AKT signaling pathway, gamma‐aminobutyric acid (GABA) receptor signaling, complement and coagulation cascades, cGMP/PKG signaling pathway, MAPK signaling pathway, and calcium signaling pathway. In parallel, emodin intervention regulated the abundance alteration of 27 brain metabolites (20 up‐regulated and 7 down‐regulated) in the CCI rats, which were primarily implicated in carbon metabolism, biosynthesis of amino acids, pentose phosphate pathway, and glucagon signaling pathway. After a comprehensive analysis and western blot validation, we demonstrated that emodin alleviated NeP mainly through regulating GABAergic pathway and PI3K/AKT/NF‐κB pathway.Keywords
Funding Information
- National Natural Science Foundation of China (82104658, 2018YFC170810522)
This publication has 60 references indexed in Scilit:
- Neuropathic pain in the general population: A systematic review of epidemiological studiesPain, 2014
- GABAA receptor modulation: Potential to deliver novel pain medicines?European Journal of Pharmacology, 2013
- A new definition of neuropathic painPain, 2011
- Inhibition of NF-kappaB prevents mechanical allodynia induced by spinal ventral root transection and suppresses the re-expression of Nav1.3 in DRG neurons in vivo and in vitroBrain Research, 2010
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Universal sample preparation method for proteome analysisNature Methods, 2009
- The role of Akt in the signaling pathway of the glycoprotein Ib-IX–induced platelet activationBlood, 2008
- Developmental toxicity evaluation of emodin in rats and miceBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2004
- Interaction between von Willebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3–kinaseBlood, 2003
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988